Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-24T16:35:54.743Z Has data issue: false hasContentIssue false
  • English
  • Français

Un estudio de seguimiento de 15 años de pacientes con trastorno de angustia

Published online by Cambridge University Press:  12 May 2020

Sven Andersch  and
Jerker Hetta
Sven Andersch
Affiliation:
Departamento de Psiquiatría, Instituto de Neurociencia Clínica, Universidad de Goteborg, Gothenburg, Suecia
Jerker Hetta
Affiliation:
Departamento de Psiquiatría, Instituto de Neurociencia Clínica, Universidad de Goteborg, Gothenburg, Suecia
Get access

Resumen

Antecedentes.

El trastorno de angustia (TA) se considera por lo general como un trastorno crónico con variación considerable en la gravedad de los síntomas.

Propósitos.

Describir la evolución a largo plazo del TA tratado de manera naturalista.

Métodos.

Cincuenta y cinco pacientes ambulatorios con TA que habían participado en un ensayo farmacológico controlado con placebo de la eficacia del alprazolam y la imipramina hacía 15 años tuvieron otra evaluación con los mismos instrumentos utilizados en el estudio original.

Resultados.

Se vio recuperación completa (ausencia de crisis de angustia y llevar los 10 últimos años sin tomar medicación) en el 18% de los pacientes, y otro 13% se recuperó pero estaba todavía con medicación. El cincuenta y uno por ciento experimentaba crisis de ansiedad recurrentes, mientras que el 18% cumplía todavía los criterios diagnósticos para el TA. La incidencia de agorafobia disminuyó del 69% al 20%. Los pacientes con agorafobia en la admisión tendían a tener una evolución a largo plazo peor según el funcionamiento diario, comparado con los pacientes sin agorafobia en la admisión, aunque ambos grupos comunicaron mejoría del funcionamiento diario en el seguimiento. La medicación de mantenimiento era común. No se informó de abuso de benzodiacepinas.

Conclusión.

El TA tiene una evolución favorable en una proporción sustancial de pacientes. Sin embargo, la enfermedad es crónica y precisa tratamiento. El tratamiento a corto plazo dado en el ensayo farmacológico no tuvo influencia en la evolución a largo plazo.

Keywords

Trastorno de ansiedadTrastorno de angustiaAgorafobiaEvolución a largo plazo
Type
Artículo original
Information
European Psychiatry (Ed. Española) , Volume 11 , Issue 2 , March 2004 , pp. 102 - 110
Copyright
Copyright © European Psychiatric Association 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bibliografía

American Psychiatric Association. Benzodiazepines. Dependence, toxicity and abuse. A task forcé report of the American Psychiatric Association. Washington (DC): APA; 1990.Google Scholar
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed.Washington (DC): APA; 1980.Google Scholar
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed.Washington (DC): APA; 1987 [revised, DSM-m-R].Google Scholar
Andersch, S, Rosenberg, NK, Kullingsjo, H, Ottosson, JO, Bech, P, Bruun-Hansen, J, et al.Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study. Acta Psychiatr Scand Suppl 1991;83(Suppl 365):18–27.CrossRefGoogle Scholar
Andersch, S, Hansson, L, Hällström, T.Panic disorder: a 5-year follow-up study in 52 patients. Eur J Psychiatry 1997;11:145–55.Google Scholar
Ballenger, JC, Burrows, GD, DuPont, RL Jr, Lesser, IM, Noyes, R Jr, Pecknold, JC, et al.Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment. Arch Gen Psychiatry 1988;45(5):413–22.CrossRefGoogle ScholarPubMed
Busto, U, Sellers, EM, Naraujo, CA, Cappell, H, Sanchez-Craig, M, Sykora, A.Withdrawal reaction after long-term therapeutic use of ben-zodiazopines. New Engl J Med 1986;315:854–9.CrossRefGoogle Scholar
Cross-National Collaborative Panic Study SPI. Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine and placebo. Br J Psychiatry 1992;160:191–202.CrossRefGoogle Scholar
Derogatis, LR, Lipman, RS, Covi, L.SCI-90: an outpatient psychiatric rating scale. Psychopharmacol Bull 1973;9(1):13–28.Google Scholar
Good, P.Permutation tests. A practical guide to resampling methods for testing hypotheses. New York: Springer; 2000. p. 51–2.Google Scholar
Good, P.Permutation tests. A practical guide to resampling methods for testing hypotheses. New York: Springer; 2000. p. 36–7.Google Scholar
Katschnig, H, Amering, M, Stolk, JM, Klerman, GL, Ballenger, JC, Briggs, A, et al.Long term follow-up after a drug trial for panic disorder. Br J Psychiatry 1995;167:487–94.CrossRefGoogle ScholarPubMed
Keller, M, Yonkers, K, Warshaw, M, Pratt, L, Gollan, J, Massion, A, et al.Remission and relapse in subjects with panic disorder and panic with agoraphobia: a prospective short interval naturalistic follow-up. J NervMentDis 1994;182:290–6.Google ScholarPubMed
Kelly, D, Guirguis, W, Frommer, E, Mitchell-Heggs, N, Sargant, W.Treatment of phobic states with antidepressants. A retrospective study of 246 patients. Br J Psychiatry 1970;116(533):387–98.CrossRefGoogle ScholarPubMed
Klein, DF, Ross, DC, Cohen, P.Panic and avoidance in agoraphobia. Arch Gen Psychiatry 1987;44:377–89.CrossRefGoogle ScholarPubMed
Klein, DF.Anxiety reconceptualized. In: Klein, DF, Raskin, J, editors. Anxiety: new research and changing concepts. New York: Raven Press; 1981. p. 235–63.Google Scholar
Lepine, J, Chignon, J, Teherani, M.Suicide attempts in patients with panic disorder. Arch Gen Psychiatry 1993;50:144–9.CrossRefGoogle ScholarPubMed
Liebowitz, MR.Panic disorder as a chronic illness. J Clin Psychiatry 1997;58(Suppl 13):5–8.Google ScholarPubMed
Maier, W, Buller, R.One-year follow-up of panic disorder. Outcome and prognostic factors. Eur Arch Psychiatry Neurol Sci 1988;238(2):105–9.Google ScholarPubMed
Maier, W, Rosenberg, R, Argyle, N, Buller, R, Roth, M, Brandon, S, et al.Avoidance behaviour and major depression in panic disorder: a report from the Cross-National Collaborative Panic Study. Psychiatr Dev 1989;7(2):123–42.Google ScholarPubMed
Noyes, R Jr, Clancy, J, Woodman, C, Holt, CS, Suelzer, M, Christiansen, J, et al.Environmental factors related to the outcome of panic disorder. A 7-year follow-up study. J Nerv Ment Disord 1993;181(9):529–38.CrossRefGoogle Scholar
Noyes, R Jr, Reich, J, Christiansen, J, Suelzer, M, Pfohl, B, Coryell, WA.Outcome of panic disorder. Relationship to diagnostic subtypes and comorbidity. Arch Gen Psychiatry 1990;47(9):809–18.CrossRefGoogle ScholarPubMed
Pollack, MH, Smoller, JW.The longitudinal course and outcome of panic disorder. Psychiatr Clin North Am 1995;18(4):785–801.CrossRefGoogle ScholarPubMed
Rickels, K, Schweizer, E, Csanalosi, I, Case, WG, Chung, H.Longterm treatment of anxiety and risk of withdrawal. Arch Gen Psychiatry 1988;45:444–50.CrossRefGoogle Scholar
Rosenberg, R, Bech, P, Mellergard, M, Ottosson, JO.Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment. Acta Psychiatr Scand Suppl 1991;365:39–45.CrossRefGoogle ScholarPubMed
Roth, M, Argyle, N.Anxiety, panic and phobic disorders: an overview. J Psychiatr Res 1988;22:33–54.CrossRefGoogle ScholarPubMed
Roy-Byrne, PP, Cowley, DS.Course and outcome in panic disorder: a review of recent follow-up studies. Anxiety 1994;1(4):151–60.CrossRefGoogle ScholarPubMed
Sheehan, DV, Lecrubier, Y, Sheehan, KH, Amorim, P, Janavs, J, Weiller, E, et al.The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl 20):22–33.Google ScholarPubMed
Sheehan, D.The anxiety disease. New York: The Scribner Book Company Incorporated; 1983. p. 135–8.Google Scholar
Sheehan, D.Benzodiazepines in panic disorder and agoraphobia. J Affect Disord 1987;13:169–81.CrossRefGoogle ScholarPubMed
Spitzer, R, Williams, J.Structured clinical interview for DSM-III-Upjohn Versión (SCID-UP 12/15/83). New York: Biometrics Research Department, New York State Psychiatric Institute; 1983.Google Scholar
Spitzer, RL, Williams, JB.Revised diagnostic criteria and a new structured interview for diagnosing anxiety disorders. J Psychiatr Res 1988;22(Suppl 1):55–85.CrossRefGoogle Scholar
Warshaw, MG, Massion, AO, Peterson, LG, Pratt, LA, Keller, MB.Suicidal behaviour in patients with panic disorder: retrospective and prospective data. J Affect Disord 1995;34(3):235–47.CrossRefGoogle ScholarPubMed
Weissman, MM, Klerman, GL, Markowitz, JS, Ouellette, R.Suicidal ideation and suicide attempts in panic disorder and attacks. New Engl JMed 1989;321(18):1209–14.CrossRefGoogle ScholarPubMed
Weissman, MM, Bland, RC, Canino, GJ, et al.The cross-national epidemiology of panic disorder. Arch Gen Psychiatry 1997;54:305–9.CrossRefGoogle ScholarPubMed
Wittchen, HU.Epidemiology of panic attacks and panic disorder. In: Hand, I, Wittchen, HU, editors. Panic and phobias: empirical evidence of theoretical models and longterm effects of behavioral treatments. Berlin: Springer; 1986. p. 18–2811.CrossRefGoogle Scholar